Automate the admin.
Accelerate the science.
Onymos DocKnow hyperautomates your R&D and regulatory workflows with AI that understands pharma. From trial startup to final submission, DocKnow delivers the speed, accuracy, and compliance that drug development demands.
Automate the admin.
Accelerate the science.
Onymos DocKnow hyperautomates your R&D and regulatory workflows with AI that understands pharma. From trial startup to final submission, DocKnow delivers the speed, accuracy, and compliance that drug development demands.
Manual document processing can’t keep up with modern drug development.
When it comes to getting new drugs to market, each day of delay costs about $800,000 in lost revenue. But document-heavy trial workflows slow down research, and preparing regulatory submissions are months-long ordeals. DocKnow changes that. It automatically processes, validates, and transforms your document data and eliminates the most tedious, time-consuming tasks for your highest-skilled workers.
Clinical Trials
DocKnow automates document processing by extracting and verifying the data points you need from any forms or medical records, whether its structured or unstructured. It makes sure every input is in compliance with regulatory guidelines. That means no delays and more submission-ready content, right from the start.
Regulatory Submissions
Preparing filings like NDAs, INDs, and CTDs takes time, and any error can cost you. Spend less time fixing those mistakes and more time moving forward. DocKnow validates (or can even generate) your submission content, so you can move faster, with fewer revisions and less back-and-forth.
Reduce Risk
Manual document processing alone isn’t just inefficient, it’s risky. Because DocKnow is trained on your documents and SOPs, it can intelligently assess and prevent bad or incomplete data from getting downstream in any of your workflows.
Strategic Intelligence
DocKnow can use AI to analyze regulatory filings, guidance updates, and competitor submissions. Your teams can monitor global trends, benchmark strategy, and anticipate what regulators expect next (without all the manual research).
Certified SOC 2 and HIPAA compliant.
Albertsons, CVS, Guardant Health, and more all use Onymos software to power their data processing, medical device technology, and rapid app development.
“From a security perspective, there was really no concern because there is no data leaving the customer’s boundary,” says Prabhakar Ramakrishnan, CloudWave President, whose company leverages Onymos DocKnow in their document digitization application for the federal government.
Certified SOC 2 and HIPAA compliant.
Albertsons, CVS, Guardant Health, and more all use Onymos software to power their data processing, medical device technology, and rapid app development.
“From a security perspective, there was really no concern because there is no data leaving the customer’s boundary,” says Prabhakar Ramakrishnan, CloudWave President, whose company leverages Onymos DocKnow in their document digitization application for the federal government.
